Lifastuzumab Biosimilar (NaPi2b / SLC34A2 Reference Antibody)
Lifastuzumab is a humanized anti-NaPi2b monoclonal antibody (IgG1 type) . Lifastuzumab can be coupled with monomethyl auristatin E (MMAE) through ADC Linker to form an antibody-drug conjugate (ADC) lifastuzumab vedotin (DNIB0600A) with anticancer activity.
Product Specifications
Target
Lifastuzumab Biosimilar (Anti-NaPi2b / SLC34A2 Reference Antibody)
Clonality
Recombinant
Conjugation
Unconjugated
Purity
>98%
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
![Rabbit Polyclonal CD133 Antibody [HRP]](https://cdn.genprice.uk/genprice/uk/genprice3.webp)
